|
The lengths of the three genes were 2 781,2 794 and 2 862 bp,respectively. The entire coding regions consisted of 11 extrons and 10 introns. There were significant homologies among those three genes.
|
|
|
3个基因的核苷酸序列长度分别是2 781、2 794、2 862 bp,基因的完全编码区含有11个外显子和10个内含子,在核苷酸序列上三个糯基因彼此之间有惊人的同源性。 |
|
The level of DNA,prostaglandin E 2(PGE 2) and the activity of superoxide dismutase(SOD),ATPase in gastric mucus were measured before and after treatment.
|
|
|
同时检测胃黏膜脱氧核糖核酸 ( DNA)、前列腺素 E2 ( PGE2 )的含量及超氧化物歧化酶 ( SOD)、三磷酸腺苷 ( ATP)酶的活性。 |
|
The level of IFN–γonly increased a little. Conclusion: HSV-1can activate the proliferation of Th1 lymphocytes and increase theproduction of Th1 type cytokines.
|
|
|
HSV-1 体外能促进小鼠T 细胞增殖和Th1 型细胞因子分泌。 |
|
The level of hydrocortisone,immunoglobulin G,immunoglobulin A,CD3,CD4 and CD3/CD4 in the treatment grouup increased obviously with no significant differences when compared with those of normal group(P>0.05).
|
|
|
治疗后血清皮质醇、血清免疫球蛋白G、血清免疫球蛋白A浓度与CD3、CD4及CD4/CD8均明显升高,与正常组比较差异无显著性意义(P>0.05)。 |
|
The level of thyroid hormone effects the metabolism of serum Hcy and lipids levels.
|
|
|
甲状腺激素水平影响了Hcy及血脂水平的代谢。 |
|
The levels of IL-15 in serum was analyzed by enzyme linked immunosorbent assay (ELISA).
|
|
|
使用酶联免疫吸附法(ELISA)测定不同组别血清IL-15水平。 |
|
The levels of T helper 1 and T helper 2 cytokines in peripheral blood of heptatitis B patients and their clinical significance
|
|
|
乙型病毒性肝炎患者外周血T辅助细胞1、2型细胞因子含量的测定及临床意义 |
|
The levels of TARC and IL-4 and IFN-γ in BALF were measured by enzyme-linked immunosorbent assay (ELISA).
|
|
|
应用酶联免疫吸附试验(ELISA)法测定BALF中TARC、IL-4和IFN-γ蛋白的浓度; |
|
The levels of urinary album in excretionrate(UAER),the serum creatinine(SCr),blood urea nitrogen(BUN),blood lipids,blood pressure(BP),C-reactive protein(CRP),glycosylated hemoglobin(GHbAl),urinary β2 microglobulin(β2-MG) after 3 months.
|
|
|
用药3个月后检测血压(BP)、血脂、微量白蛋白尿(UAER)、血肌酐(SCr)、尿素氮(BUN)、C-反应蛋白(CRP)、糖化血红蛋白(GHbAl)及尿β2微球蛋白(β2-MG)的变化,了解还原型谷胱甘肽对肾脏的保护作用。 |
|
The liver func-tion, fibrosis and PGA parameters were alsoameliorated 3 months after treatment in all the groups, especially in group C (t = 6.1201, P = 0.000; t = 20.8201, P = 0.000; t = 20.5154, P = 0.000).
|
|
|
4组改善肝功能、肝纤三项、PGA参数,治疗后3mo以内外合用组疗效显著(t=6.1201,P=0.000;t=20.8201,P=0.000;t=20.5154,P=0.000); |
|
The liver transplantation in patients with hepatic function failure
|
|
|
肝功能衰竭患者的肝移植治疗 |
